HealthCentral.com - The FDA has approved EMSAM (selegiline), a transdermal patch, for the treatment of major depression. Selegeline is a MAOI originally used to treat Parkinson’s. MAOIs belong to an old class of antidepressants, typically used as a last resort. When Read more

Xagena Medical News - According to Duke team leader Lana Watkins, the researchers believe their findings add further support for the potential role oft non-pharmocological approaches to treating depression, such as exercise, in reducing the risk of death in depressed Read more

The Australian - Perhaps the most important change in recent years is the increased community awareness of the dangers associated with not treating depression. Those who get care are more likely to be alive and back at work or school. Those who do not, , particularly Read more

InteliHealth - Though the tricyclics are as effective in treating depression as the newer antidepressants, their side effects are usually more unpleasant; thus, today tricyclics such as imipramine, amitriptyline, nortriptyline, and desipramine are used as a second Read more

This entry was posted on Monday, August 27th, 2007 at 7:30 pm and is filed under Manic Depression. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.